Inventor · disambiguated record
Bruce A. Ruggeri
Also filed as: RUGGERI BRUCE · RUGGERI BRUCE A
7 granted patents·5 pending applications·125 citations·filing 2001–2018
84Inventor score
Top patents by PatentIndex Score
12 records- 0189US6548062B2Method of treating cancer with anti-neurotrophin agentsCEPHALON INC·Filed 2001·Granted Apr 15, 2003·89 cites·15 claims
- 0284US7199122B2Methods for inhibiting angiogenesisFOX CHASE CANCER CT·Filed 2002·Granted Apr 3, 2007·26 cites·32 claims
- 0377US10028956B2Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agentsIGNYTA INC·Filed 2014·Granted Jul 24, 2018·2 cites·8 claims
- 0476US8044064B2Fused pyrrolocarbazolesCEPHALON INC·Filed 2010·Granted Oct 25, 2011·2 cites·10 claims
- 0576US7452884B2Methods for inhibiting angiogenesisFOX CHASE CANCER CT·Filed 2006·Granted Nov 18, 2008·3 cites·5 claims
- 0670US9340559B2Proteasome inhibitor delanzomib for use in the treatment of lupusRUGGERI BRUCE A·Filed 2012·Granted May 17, 2016·3 cites·10 claims
- 0757US8383813B2Fused pyrrolocarbazolesCEPHALON INC·Filed 2011·Granted Feb 26, 2013·0 cites·2 claims
- 0857US2008146556A1Method of radio-sensitizing tumors using a radio-sensitizing agentCEPHALON INC·Filed 2007·Application pending·0 cites
- 0947US2002169154A1Novel methods and compositions involving trk tyrosine kinase inhibitors and antineoplastic agentsCEPHALON INC·Filed 2002·Application pending·0 cites
- 1045US2019151317A1METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR IN COMBINATION WITH OTHER AGENTSIGNYTA INC·Filed 2018·Application pending·0 cites
- 1143US2016303116A1Treatment of multiple sclerosis with a 1,2,4-triazolo [1,5a] pyridine derivativeCEPHALON INC·Filed 2014·Application pending·0 cites
- 1242US2008021013A1JAK inhibitors for treatment of myeloproliferative disordersCEPHALON INC·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →